Indaptus Therapeutics Stock Market Value
| INDP Stock | USD 1.01 0.03 3.06% |
| Symbol | Indaptus |
Indaptus Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Indaptus Therapeutics. If investors know Indaptus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Indaptus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Return On Assets (0.71) | Return On Equity (1.27) |
The market value of Indaptus Therapeutics is measured differently than its book value, which is the value of Indaptus that is recorded on the company's balance sheet. Investors also form their own opinion of Indaptus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Indaptus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Indaptus Therapeutics' market value can be influenced by many factors that don't directly affect Indaptus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Indaptus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Indaptus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Indaptus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Indaptus Therapeutics.
| 12/24/2022 |
| 12/13/2024 |
If you would invest 0.00 in Indaptus Therapeutics on December 24, 2022 and sell it all today you would earn a total of 0.00 from holding Indaptus Therapeutics or generate 0.0% return on investment in Indaptus Therapeutics over 720 days. Indaptus Therapeutics is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, ABVC Biopharma, Pasithea Therapeutics, Nutriband, and Quoin Pharmaceuticals. Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunothe... More
Indaptus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Indaptus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Indaptus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 49.41 | |||
| Value At Risk | (9.40) | |||
| Potential Upside | 12.6 |
Indaptus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Indaptus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Indaptus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Indaptus Therapeutics historical prices to predict the future Indaptus Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | 0.6385 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Indaptus Therapeutics Backtested Returns
Indaptus Therapeutics holds Efficiency (Sharpe) Ratio of -0.0631, which attests that the entity had a -0.0631% return per unit of risk over the last 3 months. Indaptus Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Indaptus Therapeutics' Risk Adjusted Performance of (0.02), market risk adjusted performance of 0.6485, and Standard Deviation of 7.38 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.54, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Indaptus Therapeutics are expected to decrease at a much lower rate. During the bear market, Indaptus Therapeutics is likely to outperform the market. At this point, Indaptus Therapeutics has a negative expected return of -0.47%. Please make sure to check out Indaptus Therapeutics' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Indaptus Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.3 |
Weak reverse predictability
Indaptus Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Indaptus Therapeutics time series from 24th of December 2022 to 19th of December 2023 and 19th of December 2023 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Indaptus Therapeutics price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Indaptus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.22 |
Indaptus Therapeutics lagged returns against current returns
Autocorrelation, which is Indaptus Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Indaptus Therapeutics' stock expected returns. We can calculate the autocorrelation of Indaptus Therapeutics returns to help us make a trade decision. For example, suppose you find that Indaptus Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Indaptus Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Indaptus Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Indaptus Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Indaptus Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Indaptus Therapeutics Lagged Returns
When evaluating Indaptus Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Indaptus Therapeutics stock have on its future price. Indaptus Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Indaptus Therapeutics autocorrelation shows the relationship between Indaptus Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Indaptus Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Indaptus Stock
Moving against Indaptus Stock
| 0.69 | BMY | Bristol Myers Squibb | PairCorr |
| 0.57 | ESPR | Esperion Therapeutics | PairCorr |
| 0.48 | GILD | Gilead Sciences | PairCorr |
| 0.47 | DYAI | Dyadic International | PairCorr |
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.